Indianapolis-based Eli Lilly & Co. (NYSE: LLY) has announced a research collaboration with the William Sansum Diabetes Center in California. The pharmaceutical company says the partnership aims to improve the lives of Latino people affected by diabetes.
Lilly says the collaboration will provide insight into the unmet needs of Latino diabetes patients and help with the development of interventions that could improve health outcomes.
“This is a great opportunity for us to further understand the significant impact of diabetes for Latino families,” said Dara Schuster, senior director of U.S. Medical Affairs for Lilly Diabetes. “Through this collaboration, we will learn where the gaps are so we can develop meaningful solutions for the unmet needs.”